(SeaPRwire) – Everyone thinks this ETF launch was a huge success. It was not. The $16.12 million in assets looks like a victory lap. But the share count stayed at 600,000. No new investors walked in. The price just went up because the underlying token spiked. That is the core problem. You cannot build a durable financial instrument on pure momentum without actual capital inflows.
Canary Capital says the fund staked 100% of its holdings. They charge a 1.10% annual fee. Eric Chen rang the Nasdaq bell next to Steven McClurg on November 6. It looked like a major institutional endorsement. But look at the tape. The fund started with $15 million. By Friday, it hit $16.12 million. The share count did not move one cent. That $1.12 million gain came entirely from INJ rising 12.74% for the week. Investors bought existing shares. They did not create new ones. The “demand” was fake.
The real story is the risk structure. This is not a registered fund under the 1940 Act. It lacks standard investor protections. If validators fail, you get penalties. The staking yield showed 0.00% on November 6. That is a red flag. Canary is using Luganodes for staking. The system burns 7.27 million INJ. That is good for token holders. But for a retail investor buying an ETF wrapper, the lack of institutional-grade safeguards is terrifying. You are betting on a proof-of-stake chain through a vehicle that explicitly tells you it is not protected like a mutual fund.
Stop treating price appreciation as subscription volume. This fund is a closed loop right now. The liquidity provider is Flow Traders. They will keep the spread tight. But until real money flows in via share creation, this is just a small, volatile bet on Injective’s price action. The bell ringing was theater. The data is silent. If nobody buys new shares in the next two weeks, this “institutional” product is just a speculative bag holder with a fancy ticker.